Varun Venkataramani is the winner of the 2025 Eppendorf Award for Young European Investigators. A neurologist and group leader at Heidelberg University Hospital ...

The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An international research team has succeeded in deciphering a key mechanism that ...

Glucose is the fuel to the cellular engine. It powers the cell’s functions and serves as the raw material for synthesizing various essential biomolecules, including the sugar backbone of DNA and RNA.

Laboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a study shows. Laboratory experiments with cancer cells reveal two ways in which ...

Laboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows. While chemotherapies successfully treat cancers and extend ...

A look at cancer cells: Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby ...

From the deep sea to the shallow seafloor, researchers are uncovering unusual sugars that do something extraordinary to ...

Understanding the interaction between immune cells and cancer cells has important implications for cancer immunotherapies, including checkpoint inhibitor drugs and cell-based therapies, as well as ...

Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...